In a 2001 study that included 278 adults, at week 16, patients had an average of 1.4 mm growth in length (25 percent increase) and a 106 percent increase in fullness and thickness.
- The first and only FDA-approved treatment to grow eyelashes for people with inadequate lashes.
- The solution works progressively, with full results in 16 weeks.
IMPORTANT Latisse must be prescribed by a healthcare provider. A Rory-affiliated physician will evaluate your health information to determine if treatment with Latisse is appropriate. Do not use Latisse if you are pregnant, possibly pregnant, or breastfeeding, if you are allergic to Latisse or its ingredients, or if you have glaucoma or are currently using medicated drops for glaucoma. Latisse may cause brown darkening of the colored part of the eye (iris), which is likely permanent, or eyelid skin darkening, which may be reversible. If use is discontinued, lashes gradually return to their previous appearance.
